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DOI 10.1186/s12936-015-0717-0RESEARCH Open AccessN-acetyl cysteine and mushroom Agaricus sylvaticus
supplementation decreased parasitaemia and
pulmonary oxidative stress in a mice model of
malaria
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Background: Malaria infection can cause high oxidative stress, which could lead to the development of severe
forms of malaria, such as pulmonary malaria. In recent years, the role of reactive oxygen species in the pathogenesis of
the disease has been discussed, as well as the potential benefit of antioxidants supplementation. The aim of this study
was to investigate the effects of N-acetyl cysteine (NAC) or mushroom Agaricus sylvaticus supplementation on the
pulmonary oxidative changes in an experimental model of malaria caused by Plasmodium berghei strain ANKA.
Methods: Swiss male mice were infected with P. berghei and treated with NAC or AS. Samples of lung tissue and
whole blood were collected after one, three, five, seven or ten days of infection for the assessment of thiobarbituric
acid reactive substances (TBARS), trolox equivalent antioxidant capacity (TEAC), nitrites and nitrates (NN) and to assess
the degree of parasitaemia.
Results: Although parasitaemia increased progressively with the evolution of the disease in all infected groups, there
was a significant decrease from the seventh to the tenth day of infection in both antioxidant-supplemented groups.
Results showed significant higher levels of TEAC in both supplemented groups, the highest occurring in the group
supplemented with A. sylvaticus. In parallel, TBARS showed similar levels among all groups, while levels of NN were
higher in animals supplemented with NAC in relation to the positive control groups and A. sylvaticus, whose levels were
similar to the negative control group.
Conclusion: Oxidative stress arising from plasmodial infection was attenuated by supplementation of both antioxidants,
but A. sylvaticus proved to be more effective and has the potential to become an important tool in the adjuvant therapy
of malaria.
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Malaria is one of the most prevalent human infections
and a huge health, economic and social problem for
more than 40 % of the world’s population [1–3]. It is
estimated approximately 130 million cases occur each
year, resulting in 315,000 to 689,000 deaths [1], of which
90 % occur in sub-Saharan Africa, mainly in children* Correspondence: spercario49@gmail.com
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article, unless otherwise stated.under five years of age [1, 2, 4]. Two-thirds of the
remainder are concentrated in countries such as India,
Pakistan, Myanmar, Papua New Guinea, and Brazil
[1, 5]. It has been shown that the severity of the disease
is mostly related to oxidative changes caused during
Plasmodium infection. These changes occur when
reactive oxygen species (ROS) produced by the infected
red blood cell (RBC) cause imbalances of antioxidant
defense mechanisms in the host. The resulting intravas-
cular oxidative stress on endothelial cells contributes tod Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0) which permits unrestricted use,
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disease [6–9].
In this context, when antioxidant protection mecha-
nisms become unbalanced, physiological changes may
occur, resulting in disease outcomes and accelerated
aging. However, the use of antioxidant supplements may
help reduce oxidative damage and to prevent disease
evolution [8, 10–12]. Hence, it is possible that supple-
mentation with antioxidant-rich sources can exert a pre-
ventive role against malaria development and become a
protective strategy to exposed individuals, especially in
endemic areas.
Among several sources of antioxidants that can carry
out this role, two are particularly interesting: N-acetyl
cysteine (NAC), which is a precursor of the hepatic syn-
thesis of reduced glutathione (GSH) and mushrooms of
the genus Agaricus, recently identified as bearers of high
total antioxidant capacity [13, 14]. A more detailed
description of the medicinal and antioxidant properties
of this unique mushroom can be found at the Additional
file 1.
Pulmonary malaria
With regard to disease severity, pulmonary distress
resulting from Plasmodium falciparum infection are
reported in 3-10 % of cases, with variable clinical
manifestations, ranging from discrete, related to the
upper airways, to more severe complications, with
severe hypoxia, pulmonary oedema and death. Acute
pulmonary oedema is expected in approximately one-
third of fatal cases of falciparum malaria among
adults, with case fatality rates close to 70 % [15].
In children, respiratory disorder is a response to meta-
bolic acidosis, predominantly due to an increase in the
production of lactic acid and microvascular obstruction
in the presence of anaemia. In addition, rigid erythro-
cytes can exacerbate microvascular obstruction and fur-
ther impair blood flow, leading to the development of
severe malaria in the acute phase of the disease [16].
Although the participation of lungs as one of the main
components involved in the severity of malaria has been
well documented [15, 17, 18], knowledge about this
pathogenesis is still limited, despite being clinically
characterized as severe and often lethal. It is known that
the initial clinical presentation is acute respiratory dis-
tress syndrome, accompanied, in the more severe forms
of the disease, by pulmonary oedema. The mechanisms
responsible for triggering this complication seem to
precede the increase in alveolar capillaries permeability,
leading to lung fluid accumulation [17].
Nevertheless, the physiopathogenic mechanisms of
pulmonary complications in malaria are not yet well
known, and there are conflicting suggestions for the
phenomenon. In fact, some researchers believe thatpulmonary oedema is due to septic shock secondary to
co-bacterial infection [17, 19]. On the other hand, others
suggest that substances derived from parasitic infection,
such as glycophosphatidylinositols and digestive vacuoles
may contribute to the vascular changes that lead to
pulmonary malaria [20]. Also, other researchers have
described the occurrence of ischemia-reperfusion syn-
drome and the subsequent development of oxidative
stress to be the result of the cyto-adherence characteris-
tic of P. falciparum infection [14, 21, 22].
Hence, the primary objective of this study was to in-
vestigate and compare the potential benefits of anti-
oxidant supplementation with mushroom Agaricus
sylvaticus and NAC on lung oxidative changes and
their impact over parasitaemia in an experimental
model of malaria caused by Plasmodium berghei in
mice. Both objectives were fully achieved.
Methods
Two-hundred male Swiss mice (Mus musculus), young
adults (25–35 g), from the Evandro Chagas Institute
(Belem, PA, Brazil) were randomly divided into four
groups, further divided in five sub-groups each (N = 10
each), according to time of animal’s euthanasia (one,
three, five, seven or ten days after inoculation), and sam-
ples of lung tissue and blood were collected for the
evaluation of oxidative stress markers, antioxidant
defenses and degree of parasitaemia, as follows:
Negative control groups (NC); N = 10 for each sub-
group): animals that were inoculated with non-infected
erythrocytes and received physiological saline solution
(0.85 %; 0.4 mL/kg body weight, ip) before the study
period. In addition, 10 μl of sterile distilled water per
25 g of body weight (gavage) was administered two
hours before inoculation and daily, until the day of
animals’ euthanasia.
Positive control groups (PC); N = 10 for each
sub-group): animals were inoculated with
P. berghei-infected erythrocytes and received 10 μl of
sterile distilled water per 25 g of body weight
(gavage) two hours prior to the inoculation of
P. berghei and daily, until the day of animals’
euthanasia.
N-acetyl cysteine groups (NACG); N = 10 for each
subgroup): animals were inoculated with P. berghei
in the same way that groups PC and treated with
NAC, as described below, until the day of animals’
euthanasia.
Agaricus sylvaticus groups (ASG); N = 10 for each
sub-group): animals were inoculated with P. berghei in
the same way that groups PC and simultaneously treated
with mushroom Agaricus sylvaticus, as described below,
until the day of animals’ euthanasia.
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randomization using a sub-group sequence generated
after sortition [23] and were maintained in a vivarium at
the Federal University of Pará (UFPA, Belém, PA, Brazil)
in polystyrene cages containing five animals each, kept
under 12 h light/dark cycles, controlled temperature
(25 °C), and received rodent chow (Labina™, Presence,
Brazil) and tap water ad libitum for one, three, five,
seven or ten days after infection of animals for each sub-
group and, at the end of each period, animals were
submitted to heparin administration (heparin sulfate
100 IU, ip), anesthetized with 50 μL of Ketamine (5 %)-
Xylazine (2 %), sample collection, and underwent
euthanasia by hypovolemia after exsanguination. Abso-
lutely all efforts were made to minimize suffering to
animals.
After thoracotomy, blood samples were obtained by
cardiac puncture of the right ventricle and both lungs
were removed. The project followed the international
guidelines for research with experimental animals and
procedures were reviewed and approved by the Ethics
Committee in Research with Experimental Animals of
the Federal University of Pará - CEPAE/UFPA (Report
No. MED014/2008).Features of the animal model
The use of Swiss mice as model for malaria infection is
widely used and presents the same pattern of infection
progression and basic features of lung malaria as other
mice species. As described by Sadavongvivad and
Aviado [24], the main histopathological lung findings in
P. berghei-infected mice are the presence of inflamma-
tory reaction around the alveoli and intra-alveolar
haemorrhages. Moreover, the presence of large alveolar
oedema is a common finding, often causing over 40 % in-
creases in lung-to-body weight ratio [25, 26]. Additionally,
the infiltration of macrophages and lymphocytes are
observed as the infection progresses and are responsible
for septal thickening [27, 28], as well as the presence of
cytoadherence of mononuclear cells to pulmonary vessels
[28]. Taken together, the histopathological features de-
scribed are similar to those displayed in severe malaria
human cases [15].Malaria induction
Mice were kept in the vivarium for two weeks and
underwent clinical examination prior malaria induction
through intraperitoneal inoculation of 106 erythrocytes
infected with P. berghei ANKA (in 0.2 mL of sterile
saline solution). The strain of P. berghei was supplied by
the Neurochemistry Laboratory of the Federal University
of Pará - UFPA and replicated in Swiss mice by three
times before being used in animals of this study.NAC and Agaricus sylvaticus administration
NAC
A 50 mg/mL aqueous solution of N-acetyl-L-cysteine
(Fluimicil; Zambom Pharma, Italy) was prepared and
administered to the animals (0.4 mL/kg body weight;
gavage). Ten μl of NAC solution per 25 g of body weight
was administered two hours before inoculation of P. berghei
and daily until the day of animals’ euthanasia.Agaricus sylvaticus
After owner’s written consent, fresh mushrooms were
harvested in a private land at the city of Tapirai (Sao
Paulo, Brazil; coordinates: 23°54’10.4” S, 47°31’25.0” W)
and washed and brushed under tap water to remove dirt.
It was identified as A. sylvaticus by Dr D Pegler (Kew
Botanical Gardens, UK) and is not an endangered or
protected species. Next, mushrooms were quartered and
submitted to oven dehydration (60 °C, 12 h); the liquid
suspension was prepared by steeping 1 g of powdered
dried mushroom (80 meshes) in 100 mL of hot water
(60 °C), which was then double-filtered with Millipore
0.45 and 0.25 μm. The resulting aqueous solution was
administered to animals (0.2 mL/kg of body weight;
gavage) two hours before inoculation of P. berghei and
daily until the day of animals’ euthanasia.Sample obtaining and processing
Samples of lungs were collected for the evaluation of
total antioxidant capacity and markers of oxidative
stress. Lungs were exposed by thoracotomy and perfused
with PBS to wash out the blood trapped inside. The
tissue was weighed and added to PBS in the ratio of
1:10 (m:v). The homogenization process was performed
in an ultrasonic cell disruptor (Thornton, Indaiatuba,
Brazil; D Cel). During the process, the glass beaker
containing the material was kept on ice to prevent sample
damage. The homogenate was centrifuged at 175 x g
(15 min) and the supernatant collected and stored in a
freezer at −20 °C until analysed.Determination of parasitaemia
Plasmodium berghei-infected RBC were counted on
blood smears obtained by puncture of the caudal vein of
animals on the day of euthanasia (one, three, five, seven
and ten days of infection). After drying at room
temperature, the smear was fixed with methanol for
2 min and stained with Giemsa for 10 min. Subse-
quently, slides were washed in tap water and, after
drying, RBC were counted in an optical microscope
(Olympus, CX2) with 100x magnification (see Additional
file 2).
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Laboratory measurements of Trolox equivalent anti-
oxidant capacity (TEAC), thiobarbituric acid reactive
substances (TBARS) and nitrites and nitrates (NN)
were performed in duplicate on lung tissue samples.
Internal controls and standards were inserted in each
batch for the quality assurance of determinations.Determination of Trolox equivalent antioxidant capacity
(TEAC)
Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-car-
boxylic acid; Sigma-Aldrich 23881–3) is a powerful
antioxidant water-soluble analogue of vitamin E. The
method proposed by Miller et al. [29] modified by Re
et al. [30] was followed, a colorimetric technique based
on the reaction between ABTS (2,2’-Azino-bis-3-ethylben-
zothiazoline-6-sulphonic acid; Sigma-Aldrich; 1888) with
ammonium persulphate potassium (K2S2O8; Sigma-
Aldrich; 60490), producing the radical cation ABTS●+,
chromophore of green/blue colour. The addition of anti-
oxidants to ABTS● + reduces it again to ABTS, on a scale
dependent on antioxidant capacity, concentration of anti-
oxidants and duration of the reaction. This can be
measured by spectrophotometry by observing the change
in absorbance read at 734 nm for 5 min (Fento, Sao Paulo,
Brazil; 800 XI). Finally, the total antioxidant activity of the
sample is calculated as its relationship with the reactivity
of the Trolox as standard, through the implementation of
standard curve under the same conditions.Determination of thiobarbituric acid reactive substances
(TBARS)
TBARS is a method that evaluates lipid peroxidation
and was used as an indicator of oxidative stress. This
technique is based on the reaction of malondialdehyde
(MDA), among other substances, with thiobarbituric
acid (TBA) (Sigma-Aldrich T5500), in low pH and high
temperature, yielding MDA-TBA complex of pink
colour, and absorbance peak at 535 nm.
The technical procedure was performed according to
the protocol proposed by Khon and Liversedge [31],
adapted by Percario et al. [32]. In brief: initial TBA solu-
tion (10 nM) was prepared in phosphate monobasic
potassium (KH2PO4 75 mM; Synth; 35,210) adjusted to
pH 2.5 with acetic acid. Two-hundred and fifty μL of
sample was added to 500 μL of TBA solution, mixed
and placed in a water bath (95 °C x 60 min); after cool-
ing at room temperature, 2.0 ml of 1-butanol was added,
vortex mixed and subsequently centrifuged (175 × g ×
15 min); 1.0 ml of the supernatant was collected and
read at 535 nm (Fento, São Paulo, Brazil; 800 XI).
1,1,3,3, tetraethoxypropane (Sigma-Aldrich; T9889) was
used for the implementation of the standard curve.Nitrites and nitrates (NN)
Much of nitric oxide (NO) released into the bloodstream
is swept by haemoglobin in erythrocytes or converted to
nitrite (NO2
●-) in the presence of molecular oxygen.
Nitrite reacts with oxyhaemoglobin, leading to the for-
mation of nitrate (NO3
●-) and methaemoglobin. Due to
its stability, NO2
●- has been widely used to confirm the
prior existence of NO [33]. The evaluation of this
parameter was performed by means of spectropho-
tometry (Kit Total Nitrite/Nitrate, R & D Systems,
KGE001). This technique is based on the quantitative
determination of NO, involving the enzyme nitrate
reductase, which converts nitrate to nitrite, followed
by colorimetric detection of nitrite as a product of
pink colour, produced by the Griess reaction and that
absorbs visible light at 540 nm (PerkinElmer, Victor
X3). Nitrite concentration was calculated based on the
absorbance found in the nitrites standard curve.Statistical analysis
Sample size was calculated by the method proposed by
Dell et al. [34]. The occurrence of discrepant values
(outliers) was investigated through calculation of inter-
quartile range, which calculates the difference between
the third quartile (Q3) and the first quartile (Q1), called
dj. Any value lower than Q1 - 3/2 dj or greater than
Q3 + 3/2 dj, was considered as outlier and, therefore,
removed from mathematical calculations.
Aiming at investigating the existence of statistically
significant differences between the studied variables
between the groups, two factors analysis of variance
(ANOVA) was applied, when the assumption of
normality and homoscedasticity was met, or the
Mann–Whitney test, when the assumption of normal-
ity was not met, which occurred in the case of variable
parasitaemia. The tests used to access the normality and
homoscedasticity of the variables were Kolmogorov-
Smirnov and Levene tests, respectively. When the null
hypothesis between mean differences between the vari-
ables of the study groups was rejected, Tukey’s test was
applied, and when a statistically significant difference
between medians was detected, Dunn’s test was applied.
In addition, within the same group the differences
between the initial values (one day of infection) and late
values (ten days of infection) were studied by the
Student’s unpaired t test.
The existence of correlation between the variables was
also analysed by Pearson’s correlation coefficient, considering
all points obtained in all groups simultaneously and
separately for each group studied. For the purposes of
tests ANOVA and Mann–Whitney, statistical package
SigmaStat version 3.5 was used, whereas for the
calculation of correlations the statistical package SPSS
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considering the significance level of 5 % (p < 0.05).Results
Figure 1 shows the evolution of the parasitaemia of
the positive control group and in the groups infected
and supplemented with antioxidants. The parasitaemia
increased in temporal scale for all three infected
groups, being that on the tenth day of infection it was
reduced in animals supplemented with NAC (37 ± 3 %,
p = 0.0031) and A. sylvaticus (33 ± 4 %, p = 0.0016)
when compared to group PC (52 ± 9 %).
In relation to the TEAC, all infected groups (PC,
NACG and ASG) showed gradual elevation over time,
with statistically higher values on the tenth day after
infection, however, group ASG presented the highest
elevation of total antioxidant capacity in relation to
the other groups (4.0 ± 1.5 mmol/L for NC; 13.6 ±
4.5 mmol/L for PC; 18.6 ± 3.5 mmol/L for NACG; and,
28.1 ± 5.8 mmol/L for ASG; p < 0.0001) at the end of
the study and throughout the period of infection
(Fig. 2). In the same way, NACG showed higher anti-
oxidant capacity if compared to the negative control
group at three (7.3 ± 0.8 versus 2.5 ± 1.0 mmol/L,
respectively; p < 0.01), seven (16.5 ± 5.0 versus 4.8 ±
0.6 mmol/L, respectively; p < 0.01) and ten days of
infection (18.6 ± 3.5 versus 4.0 ± 1.5 mmol/L, respect-
ively; p < 0.01) and also against the positive control
group on the third (7.3 ± 0.8 versus 3.8 ± 0.8 mmol/L,
respectively; p < 0.01) and seventh days (16.5 ± 5.0
versus 6.0 ± 0.5 mmol/L, respectively; p < 0.01).Fig. 1 Parasitaemia progression in Plasmodium berghei-infected mice and
PC = animals infected with P. berghei, but not supplemented; NC = anima
10; 3 days N = 10/10; 5 days N = 10/10; 7 days N = 10/10; 10 days N = 10/10); PC
10 days N = 6†/10); NAC (1 day N = 10/10; 3 days N= 10/10; 5 days N = 10/10; 7
5 days N = 10/10; 7 days N = 8†/10; 10 days N = 5†/10). Discrepancies in group s
sylvaticus (AS) and p = 0.0031 versus NAC, τ p< 0.0001 versus AS and p = 0.0034In addition, in PC group there was an increase in
TBARS levels with the progression of the disease from
the first to the tenth day of infection (2.1 ± 1.2 mmol/L
and 5.1 ± 0.9 mmol/L, respectively; p = 0.0002). Simi-
larly, there was a significant increase of TBARS in the
groups of supplemented animals when compared
the tenth day of infection versus the third day for the
same groups (6.5 ± 1.9 mmol/L and 2.4 ± 0.8 mmol/L,
respectively; p = 0.0001 for NACG and 3.7 ± 1.2 mmol/
L and 1.9 ± 0.7 mmol/L, respectively; p = 0.0020 for
ASG). Moreover, the group of animals supplemented
with NAC presented higher levels of TBARS in relation
to the other groups on the first day of infection
(6.8 ± 1.8 mmol/L for NACG; 3.5 ± 2.0 mmol/L for
ASG; 2.1 ± 1.2 mmol/L for PC, and 1.3 ± 0.1 mmol/L
for NC; p < 0.01). No significant differences were ob-
served between NACG or ASG and positive control
group for three, five, seven, or ten days of infection.
However, ASG has presented lower levels of TBARS than
NACG on the tenth day of infection (3.7 ± 1.2 mmol/L and
6.5 ± 1.9 mmol/L, respectively; p < 0.01; Fig. 3).
Similarly, in relation to the levels of NN, NACG
showed progressive increase with the time of infection
since the first day (p = 0.0025), while group PC pre-
sented a less pronounced increase than the NACG and
was statistically significant from the fifth day of infec-
tion (p < 0.05). Animals supplemented with NAC
presented values of NN significantly elevated compared
to ASG and NC (p < 0.01 and p < 0.01, respectively)
from the third to the tenth day of the study, in addition
to values higher than the PC group from the fifth to
tenth day of infection (p < 0.05). On the other hand,supplemented with N-acetyl cysteine (NAC) or Agaricus sylvaticus.
ls not infected and not supplemented. Group size: NC (1 day N = 10/
(1 day N = 10/10; 3 days N = 10/10; 5 days N = 8†¶/10; 7 days N = 7†/10;
days N = 8†/10; 10 days N = 6†/10); AS (1 day N = 10/10; 3 days N = 10/10;
ize were due to dead animals (†) or outliers (¶). * p = 0.0016 versus Agaricus
versus NAC
Fig. 2 Pulmonary Trolox equivalent antioxidant capacity (TEAC) of Plasmodium berghei-infected mice in groups supplemented with N-acetyl
cysteine (NAC) or Agaricus sylvaticus and control groups. PC = animals infected with P. berghei, but not supplemented; NC = animals not infected
and not supplemented. Group size: NC (1 day N = 10/10; 3 days N = 10/10; 5 days N = 9¶/10; 7 days N = 10/10; 10 days N = 10/10); PC (1 day N = 10/10;
3 days N = 9¶/10; 5 days N = 9†/10; 7 days N = 6†¶/10; 10 days N = 6†/10); NAC (1 day N = 10/10; 3 days N = 8¶/10; 5 days N = 10/10; 7 days N = 8†/10;
10 days N = 6†/10); AS (1 day N = 10/10; 3 days N = 9¶/10; 5 days N = 10/10; 7 days N = 8†/10; 10 days N = 5†/10). Discrepancies in group size were due
to dead animals (†) or outliers (¶).* p < 0.0001 versus PC, NAC, or NC. τ p < 0.01 versus NC. € p < 0.01 versus PC
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levels similar to those presented by the negative
control group throughout the study period (Fig. 4; see
Additional file 3).Correlation studies
The analysis of correlation between TBARS and NN
showed weak positive correlation for groups PC and
NACG (r2 = 0.0895, p = 0.0008 and r2 = 0.1598, p = 0.0174,Fig. 3 Pulmonary thiobarbituric acid reactive substances (TBARS) of Plasmo
cysteine (NAC) or Agaricus sylvaticus and control groups. PC = animals infec
and not supplemented. Group size: NC (1 day N = 8¶/10; 3 days N = 10/
(1 day N = 10/10; 3 days N = 10/10; 5 days N = 9†/10; 7 days N = 7†/10; 10
10; 7 days N = 8†/10; 10 days N = 6†/10); AS (1 day N = 10/10; 3 days N = 10/1
group size were due to dead animals (†) or outliers (¶).* p < 0.001 versus PC, N
p < 0.05 versus NCrespectively), however, for ASG this correlation was not
significant (r2 = 0.0001 and p = 0.3328; see Additional
file 4).
Additional file 5 show the correlation between TEAC
and NN, demonstrating the existence of moderate positive
correlation of highly significance for NACG (r2 = 0.3562,
p = 0.0002). On the other hand, in ASG a weak negative
correlation was found (r2 = −0.0394, p = 0.0120).
In relation to parasitaemia, there was a positive
correlation with TEAC (see Additional file 6), NN (seedium berghei-infected mice in groups supplemented with N-acetyl
ted with P. berghei, but not supplemented; NC = animals not infected
10; 5 days N = 10/10; 7 days N = 10/10; 10 days N = 9¶/10); PC
days N = 6†/10); NAC (1 day N = 8¶/10; 3 days N = 8¶/10; 5 days N = 10/
0; 5 days N = 10/10; 7 days N = 8†/10; 10 days N = 5†/10). Discrepancies in
AC, or Agaricus sylvaticus (AS). τ p < 0.01 versus PC, € p < 0.01 versus AS, #
Fig. 4 Pulmonary nitrites and nitrates (NN) of Plasmodium berghei-infected mice in groups supplemented with N-acetyl cysteine (NAC) or Agaricus
sylvaticus and control groups. PC = animals infected with P. berghei, but not supplemented; NC = animals not infected and not supplemented.
Group size: NC (1 day N = 9¶/10; 3 days N = 8¶/10; 5 days N = 9¶/10; 7 days N = 8¶/10; 10 days N = 9¶/10); PC (1 day N = 9¶/10; 3 days N = 10/10;
5 days N = 9†/10; 7 days N = 7†/10; 10 days N = 6†/10); NAC (1 day N = 10/10; 3 days N = 8¶/10; 5 days N = 9¶/10; 7 days N = 6†¶/10; 10 days N = 6†/10);
AS (1 day N = 10/10; 3 days N = 10/10; 5 days N = 9¶/10; 7 days N = 8†/10; 10 days N = 5†/10). Discrepancies in group size were due to dead animals (†)
or outliers (¶). * p < 0.01 versus Agaricus sylvaticus (AS) or NC, τ p < 0.01 versus PC, # p < 0.05 versus NC or AS
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considering all values obtained in all groups and sub-
groups simultaneously (r2 = 0.2153, p < 00001; r2 = 0.0707,
p = 0.0012, r2 = 0.1042, p = 0.0003, respectively), as well as
for PC (r2 = 0.5273, p < 00001; r2 = 0.3068, p = 0.0474 and
r2 = 0.5839, p < 0.0001, respectively). For NACG, a positive
correlation between parasitaemia and NN (r2 = 0.3367,
p = 0.0003) and between parasitaemia and TEAC (r2 =
0.6622, p < 0.0001) was also found. In ASG, positive
correlations between parasitaemia and TEAC and para-
sitaemia and TBARS were found (r2 = 0.8242, p < 00001
and r2 = 0.4265, p = 0.0068, respectively), in addition
to negative correlation between parasitaemia and NN
(r2 = −0.4410, p = 0.0044).
Discussion
Severe forms of malaria are generally accompanied by
impairment of pulmonary tissue, initially involving the
acute respiratory distress syndrome, accompanied, in the
more severe forms of the disease, by acute pulmonary
oedema [17, 35]. These changes may be the result of the
cyto-adherence phenomenon, particularly peculiar to P.
falciparum, likely involving ischemia and reperfusion
syndrome, with consequent free radical production and
oxidative stress [9, 21, 22]. Thus, the evaluation of the
involvement of oxidative stress and its correlation with
the parasitaemia in the severe forms of the disease, as
well as the potential beneficial effect of the use of
antioxidants, may provide a new approach to the treat-
ment of disease, especially in children who live in
endemic areas.However, studies of the potential beneficial effects of
supplementation with antioxidants performed so far
presented complex and often conflicting results [12],
creating a discouraging expectation for the practical
application of these supplements in the adjuvant therapy
of malaria. Nevertheless, the analysis of the effects of
antioxidant supplements is very difficult and complex, as
they elapse from direct actions of the supplements on
target molecules, but also depend on a large number of
mechanisms of indirect interaction, often related to
multiple pathways of cellular signaling. The choice of
antioxidant supplements employed in this study was
based on the antioxidant properties they present. For
example, NAC is an exogenous source of glutathione
[36, 37], which is one of the most important endogenous
antioxidant molecules, whereas mushroom A. sylvaticus
is composed of various antioxidant molecules that, in
combination, have one of the highest values of antioxi-
dant capacity currently found in natural products [14]. It
is responsible for several therapeutic and preventive
effects reported in recent literature [11, 38–42]. Never-
theless, it was never used before against malaria.
Additionally, NAC is commercially used for the treat-
ment of lung disorders whereas AS is commonly used
as an antioxidant supplement in Brazil. In both cases a
decision was made to use the average dose employed
for humans, i.e. 20 mg/kg of body weight for NAC and
2 mg/kg of body weight for AS.
The analysis of the present results showed that, as
expected, parasitaemia progresses in temporal scale in
the positive control group (Fig. 1), which is in agreement
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rodent models of malaria [4, 43–45]. For NACG and
ASG, there was similar behaviour to that of the positive
control, however, in addition to presenting a lower pro-
gression rate than the positive control group, there was
a significant decrease of parasitaemia from day 7 of in-
fection, suggesting the parasite requires a pro-oxidant
environment to develop and that antioxidant supple-
mentation is unfavourable for the progression of this in-
fection. This suggestion is strengthened by the finding of
significant positive correlation between parasitaemia and
TBARS - marker of oxidative stress - for the animals in
the positive control group and that it is abolished in
groups of animals supplemented with antioxidants (see
Additional file 8).
Moreover, animals treated with AS displayed an aver-
age of 43 % parasitemia reduction when compared with
PC animals, whereas NAC animals displayed an average
of 29 % reduction. Despite no significant differences to
animals’ survival in the short term (see Additional file 9),
this important decrease in parasitemia undoubtedly re-
flects the effects of both supplements over parasite de-
velopment. Eventually, this might lead to a positive
reflex over time. Alternatively, the lack of differences in
the survival rate could be a result of the relatively small
number of animals in each group, and large scale studies
might show better results.
Likewise, parasitaemia total antioxidant capacity also
increases during infection for all groups infected with
Plasmodium (PC, NACG and ASG; Fig. 2), which suggests
mobilization of endogenous antioxidant molecules by the
host as a probable mechanism of defence against oxidative
stress generated during malarial infection. In fact, in an
attempt to prevent oxidative stress, pulmonary micro-
environment seems to rely on a strong antioxidant defence,
in particular in the course of respiratory deficiency syn-
dromes. Substances potentially responsible for this process
are: proteins A1, A2 and B of alveolar surfactant [46], the
enzymes catalase [47] and superoxide dismutase [48, 49], in
addition to GSH [50].
Nevertheless, in antioxidant-supplemented groups,
TEAC was even higher than in the control group, being
found in ASG values significantly higher as compared to
the other groups throughout the period of infection
(Fig. 2). In addition, NACG showed higher antioxidant
capacity if compared to the negative control group at
three, seven and ten days of infection (p < 0.01) and also
against positive control group on the third and seventh
days (p < 0.01).
The increase of TEAC on the tenth day of infection in
groups of animals supplemented with antioxidants oc-
curred simultaneously with the decrease of parasitaemia
during this period, particularly in animals supplemented
with A. sylvaticus (p < 0.01, Fig. 2; see Additional file 6),which may suggest the existence of a particular level of
antioxidant defence from which parasitaemia does not
progress, likely because once the body creates an anti-
oxidant environment unfavourable to the development
of the parasite, disease may progress to resolution.
The fact is that in all the infected groups individually,
there was a positive and highly significant correlation
between parasitaemia and TEAC (see Additional file 6).
This strongly suggests that as parasitaemia increases, the
mobilization of endogenous antioxidant defences by
pulmonary cells occurs, increasing total antioxidant
capacity in an attempt to combat the infection, and that
supplementation with antioxidants intensify this response
even more.
Moreover, the presence of oxidative stress was
assessed by TBARS levels, which increased with the pro-
gression of the disease for all infected groups (Fig. 3),
suggesting that oxidative stress may result from infec-
tion, and increase significantly, even precociously. This
oxidative stress may be a mechanism of host’s natural
defence, depending on the activation of phagocytes
(macrophages and neutrophils), which generate large
amounts of ROS, causing an imbalance between the for-
mation of oxidant and antioxidant molecules. This can
lead to endothelial cell apoptosis and the worsening of
the disease, as suggested by Hemmer et al. [51] and
Trivedi et al. [52]. However, at least apparently, supple-
mentation did not promote the reduction of TBARS
levels in comparison to the PC group. However, when
compared with each other, the groups supplemented
with antioxidants showed significant differences on the
tenth day of infection, with ASG displaying lower values
of TBARS than NACG, reinforcing the suggestion that
mushroom Agaricus sylvaticus supplementation had the
ability to generate a more pronounced antioxidant de-
fence in animals.
In relation to NN levels (Fig. 4), the increase found in
positive control group animals suggests the involvement
of nitric oxide synthesis due to malarial infection, a fact
reinforced by the existence of significant positive correl-
ation between parasitaemia and NN, as well as between
TBARS and NN for the positive control group. These re-
sults are in agreement with several studies [53–56] and
corroborate with the suggestion that NO synthesis is a
protective factor against the development of severe mal-
aria [57, 58]. Additionally, due to the simultaneous in-
crease of free radicals, as suggested by TBARS levels
found, there is a great possibility of radical peroxynitrite
(ONOO●-) formation from the reaction between NO
and superoxide radical (O2
●-) probably produced by in-
tensification of inflammatory process or resulting from
ischemia and reperfusion, as a result of cyto-adherence
of parasitized erythrocytes to pulmonary capillaries’
endothelium. Furthermore, there is the possibility of NO
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lead to pulmonary hypertension, as has been studied by
Janka et al. [59].
On the other hand, animals supplemented with NAC
showed values of NN significantly higher than group
AS (p <0.01) from the third day of infection, as well as
in relation to the positive control group since the fifth
day of infection (p <0.01). This may be the result of
the ability of NAC to induce NO synthesis [60–62]. In par-
allel, there was a moderate positive and highly significant
correlation between parasitaemia and NN in this group of
animals (r2 = 0.3367 and p = 0.0003) whereas ASG showed
a negative correlation (r = −0.4410 and p = 0.0044; see
Additional file 7). In addition, in NACG it was also found
positive and significant correlation between TBARS and
NN (r2 = 0.1598 and p = 0.0174; see Additional file 4).
In the correlation study between TEAC and NN, a
moderate positive and highly significant correlation
(r2 = 0.3562, p = 0.0002; see Additional file 5) between
the parameters was observed for NACG.
These data reinforce the suggestion that NAC is re-
lated to the induction of NO and that it is associated
with an increase in the total antioxidant capacity. In this
sense, NAC can prevent or reverse haem’s harmful
effects and act against oxidative damage to erythrocytes’
cytoskeleton [63], as well as act as a reducing agent due
to the presence of the thiol group in the side chain of
the molecule, and that it facilitates the expression of in-
ducible nitric oxide synthase (iNOS) by IL-1β in vascular
cells of rats [59, 64–66].
In children with severe malaria, NAC increases the
normalization rate of plasma lactate by a mechanism
dependent on TNF, possibly by increasing the deformity
of RBC or by an increase in GSH [67]. Therefore, redu-
cing agents, such as NAC, may have a therapeutic role
in the complications of malaria and can reduce micro-
vascular obstruction to the blood flow. Indeed, recent
studies show that the increase in NO production has
shown beneficial effects against malarial infection, but,
although there is still controversy in this regard, these
effects may be due to cyto-adherence inhibition through
the reduction of the expression of intercellular adhe-
sion molecule 1 (ICAM-1), vascular cell adhesion
molecule 1 (VCAM-1), and E-selectin, which are
involved in cyto-adherence and microvascular seques-
tration of parasitized RBC and that impairs the pro-
duction of tumour necrosis factor alpha (TNF) by
macrophages [68].
Nevertheless, if the induction of NO synthesis is
exacerbated, the increase in NO levels, in association
with the increase of ROS, can contribute to the severity
of the disease at the pulmonary level. In this sense, Zhu
et al. [69] observed that P. falciparum glycosylphosphati-
dylinositols induce the expression of iNOS and canpositively regulate the expression of adhesion molecules
by the vascular endothelium, probably implicated in
parasite internalization to RBC. Anstey et al. [70], study-
ing adults with vivax malaria and not complicated falcip-
arum malaria, observed a reduction of the volume of
pulmonary capillaries due to sequestration of parasitized
red blood cells in the alveolar capillaries and of leuko-
cytes in pulmonary vessels, as well as that the injuries
caused to alveolar capillaries are due to inflammatory
response to destroy the parasite or by reperfusion injury.
Contrary to NACG, the animals supplemented with
Agaricus sylvaticus curiously showed levels of NN simi-
lar to the negative control group (Fig. 4; see Additional
file 3), which suggests that during infection A. sylvaticus
acts by inhibiting NO synthesis, by means of an intrinsic
mechanism, or through direct NO scavenging, favouring
the creation of an antioxidant environment within eryth-
rocytes unfavourable to parasite internalization and fur-
ther development, and probably decreasing apoptosis,
contributing to cell integrity of pulmonary capillaries.
In ASG, a negative and significant correlation
between TEAC and NN was found (r2 = −0.0394 and
p = 0.0120; see Additional file 5), which reinforces the
idea that A. sylvaticus may be involved in the inhib-
ition of the synthesis and/or decrease in pulmonary
NO concentration, with consequent increase of total anti-
oxidant capacity. The same behaviour was found for the
correlation between parasitaemia and NN (r2 = −0.4410
and p = 0.0044; see Additional file 7), strongly suggesting
that A. sylvaticus plays an inhibitor role upon pulmonary
NO synthesis and/or on the decrease of NO concentra-
tion as parasitaemia progresses, probably through an
antioxidant defence pathway against infection. This
suggestion is in agreement with Dimmeler et al. [71]
who observed that TNF-α induced endothelial cells
apoptosis was diminished after iNOS inhibition by N-
monomethyl-L-arginine (L-NMMA). Furthermore, Pino
et al. [72] observed that the adhesion of parasitized
erythrocytes to human pulmonary endothelium may be
regulated by TNF-α, cytokine that induces the expres-
sion of iNOS enzymes, suggesting that the inhibition of
NO synthesis may protect pulmonary endothelial cells.
Nevertheless, A. sylvaticus and NAC seem to act by
two distinct mechanisms in order to fight the infection.
On the one hand, NO synthesis inhibition by A. sylvaticus
seems to be a little more relevant than the effects of NAC
and probably exerts its effects in the longer term, by
inhibiting infection-induced NO synthesis, keeping NO
levels equivalent to baseline values and decreasing
endothelial apoptosis and the internalization of the para-
site in RBC. On the other hand, the induction of NO
synthesis stimulated by NAC also presents some beneficial
effect on parasite clearance and can improve microcircula-
tory flow, but seems to be dependent on high NO
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the disease, due to the production of other NO-derived
molecules, such as ONOO●-. At the same time, NAC can
act by scavenging ROS generated during infection and in-
creasing total antioxidant capacity.
Conclusion
Supplementation with both antioxidants promoted the
reduction of parasitaemia and increase in antioxidant
capacity, being both effects more pronounced in animals
supplemented with A. sylvaticus. Agaricus sylvaticus and
NAC possibly act by two distinct mechanisms in order
to decrease plasmodial infection, as A. sylvaticus seems
to act by inhibiting NO synthesis and increasing total
antioxidant capacity, while NAC can act by inducing NO
synthesis. Nevertheless, further studies are required to a
better understanding about the precise mechanism by
which antioxidants act upon evolution of parasitaemia
and disease development, as well as its repercussions on
the development of cerebral malaria, opening up new
possibilities for the adjuvant therapy of this disease or
other diseases involving oxidative stress.
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